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E-mail address: akiko.hata@ucsf.edu (A. Hata).microRNAs (miRNAs) are small non-coding RNAs conserved in metazoans. Depletion of miRNAs
results in embryonic lethality, suggesting they are essential for embryogenesis. Similarly, pathways
induced by growth factors of the transforming growth factor b (TGF-b) superfamily control cell
growth, differentiation, and development. Recently Smad proteins, the signal transducers of the
TGF-b pathway, were found to regulate miRNA expression, which, in turn, affects expression of
numerous proteins. Smads modulate miRNA expression through both transcriptional and post-tran-
scriptional mechanisms illustrating the complexity of gene regulation by TGF-b. In this chapter we
summarize the current knowledge of mechanisms underlying Smad-mediated regulation of miRNA
biogenesis.
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miRNA proﬁling study suggests that miRNAs are globally re-
duced in tumor samples as compared to normal tissues [1]. An-
other study found that miRNA signatures are a better indicator of
tumor source and prognosis than similarly developed mRNA signa-
tures [2]. Deregulation of miRNAs is a critical component of both
developmental defects and pathogenesis. Thus, miRNAs are inte-
gral to basic physiological functions in metazoans similar to the
TGF-b super family of growth factors. It is not too surprising, then,
that miRNAs are themselves critical components of the TGF-b sig-
naling pathway, nor that the Smad proteins have developed several
different mechanisms for regulating miRNA expression and activ-
ity. Below, we discuss the recent advances made in understanding
the diverse mechanisms of miRNA regulation utilized by the TGF-b
signaling pathway and the implications of this regulation to human
diseases.
2. miRNA biogenesis
Since the original description of miRNAs in 1993 [3], they have
emerged as critical regulators of nearly every aspect of mammalian
biology. By one estimation more than 60% of protein-coding re-chemical Societies. Published by E
search Institute, University of
, Rm. 252T, San Francisco, CAgions in the human genome display areas of deep conservation
in their 30 UTR indicative of targeting by miRNAs [4]. miRNAs are
important regulatory factors that mediate the expression of large
numbers of proteins. Proﬁling studies show that a single miRNA
may tune the expression of over 100 different proteins [5]. Partial
complementarity between miRNA sequences and their target
mRNAs usually occurring in the 30-UTR, mediates translational
repression or, more commonly, destabilization of the mRNAs
[6,7]. Interestingly, speciﬁc recognition of target mRNAs by a miR-
NA does not require 100% sequence complementarity [6]. Rather,
the 6–8 nucleotides at the 50 end of the miRNA, known as the ‘‘seed
sequence’’ or miRNA recognition element (MRE), confer the most
critical determinants for targeting mRNAs; though other nucleo-
tides may also be important under certain circumstances [8]. Be-
cause a relatively small number of bases is required to induce
silencing, a large number of transcripts can be targeted by a single
miRNA, however, the degree of change for any single transcript is
relatively small at 30–50% reduction [9].
miRNA biogenesis begins in the nucleus where they are tran-
scribed by RNA polymerase II (RNA Pol II) as long transcripts
known as primary miRNA (pri-miRNA) [10] (Fig. 1). Like mRNAs,
pri-miRNAs are poly-adenylated at the 30 end and bear a 7-
methyl-guanosine cap at the 50 end [11]. Pri-miRNA is cleaved by
the RNase III enzyme Drosha into a shorter (<100 bp) transcript
known as the precursor miRNA (pre-miRNA) composed of a
stem-loop structure which encodes the mature miRNA sequence
in the stem [12]. Drosha acts as part of a large processing complex
that consists of multiple proteins, including the DiGeorge criticallsevier B.V. All rights reserved.
Fig. 1. miRNA biogenesis pathway. Biosynthesis of miRNAs begins in the nucleus with the transcription of miRNA genes by RNA Pol II as long transcripts bearing a 7 methyl-
guanosine cap at the 50-end and a poly (A) tail at the 30-end. The Drosha microprocessor complex, the minimal components of which are DGCR8 and Drosha, cleaves the pri-
miRNA into pre-miRNA. Exportin 5 then exports the pre-miRNA into the cytoplasm where it undergoes a secondary processing step into a short miRNA duplex by Dicer. The
miRNA duplex contains both a mature miRNA strand and a miRNA⁄ strand. The mature miRNA is loaded into Ago proteins and mediates the silencing function as a part of the
RISC, while the miRNA⁄ gets degraded.
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binding protein that stabilizes the association of Drosha with pri-
miRNA and determines the precise location of the processing; it
is therefore essential for miRNA maturation [13]. Interestingly,
Dgcr8 and Drosha cross-regulate expression of one another pre-
sumably to maintain homeostatic control of miRNA biogenesis
[15]. Drosha destabilizes Dgcr8 mRNA through the hairpin struc-
ture in the 50-UTR of the mRNA while Dgcr8 stabilizes the Drosha
protein [15]. Although Drosha and Dgcr8 comprise the minimum
components of the microprocessor complex, many more proteins
have been identiﬁed that interact with this large structure. Two
of these proteins are the DEAD-box helicase proteins p68 (also
known as DDX5) and p72 (DDX17) [16]. Deletion of either p68 or
p72 leads to embryonic lethality, however neither protein is abso-
lutely essential for miRNA development as deletion of either from
mouse embryonic ﬁbroblasts (MEFs) disrupts the expression a dis-
tinct, but overlapping, set of miRNAs [16].
Following the cleavage of pri-miRNA by the Drosha micropro-
cessor complex, the pre-miRNA is exported from the nucleus
through the cooperative activity of Ran-GTP, which provides energy
and exportin-5 (EXP5), which interacts with the stem-loops struc-
ture of pre-miRNAs [17]. Once in the cytoplasm, the pre-miRNA
hairpin associates with another RNase III enzyme called Dicer,
which further cleaves it into a double-stranded, miRNA duplex of
approximately 22 nt, containing the guide strand (or mature
miRNA) and the passenger strand (or miRNA⁄) [17]. The miRNA
duplex is then loaded into argonaute (Ago) proteins, which select
the guide strand and present it to the RNA-induced silencing
complex (RISC) for targeting and silencing. Mature miRNAs can be
generated from either the 50 or the 30 arm of the miRNA duplex,
but it is rare for both strands to remain at high levels in the cell
as the passenger strand is quickly degraded [14].
3. Smad signaling
The TGF-b family is a pleiotropic group of growth factors that
activate an evolutionarily conserved signal-transduction cascade.
TGF-b family ligands include TGF-b itself, integrins and bone mor-
phogenic proteins (BMP). This ligand variety (46 human open read-
ing frames or ORFs) is mirrored by a large degree of receptor
diversity as well (12 human TGF-b receptors) [18]. However, this
receptor diversity can be separated into two different classes ofreceptors termed type I and type II receptors. Both receptor classes
contain serine–threonine kinase domain and ligand binding in-
duces heterodimerization between the two types of receptor.
TGF-b is originally bound by the constitutively active type II recep-
tors which induces binding, phosphorylation and activation of the
type I receptor which propagates signal transduction into the cell.
Despite its receptor and ligand diversity, TGF-b family signal
transduction is carried out by a relatively small number of con-
served proteins known as Smads. Smads can be grouped into two
distinct sets of proteins, the receptor-speciﬁc Smads (R-Smads)
and the common Smad (co-Smad/Smad4). R-Smads are only phos-
phorylated upon receptor dimerization by their speciﬁc receptors;
with the BMP receptors activating Smads 1, 5 and 8 and the TGF-b
receptors activating Smads 2 and 3 [18]. Upon phosphorylization,
R-Smads dimerize with Smad-4 and translocate into the nucleus
as a complex. This interaction with Smad4 is essential for Smad-
mediated transcriptional activity [19]. Once in the nucleus the R-
Smad-Smad4 complex binds to the Smad-binding element (SBE)
canonically identiﬁed as the heptamer 50-CAGAC-30. Though the
SBE is sufﬁcient to modulate Smad binding and activation, addi-
tional co-factors are necessary for strong activation of any ORF
[20]. In addition to these primary effector molecules a number of
other modulatory pathways exist including two inhibitory Smads,
Smad6 and Smad7, and the Smad inhibiting protein 1 (SIP1).
Because of their deep conservation it is probably not surprising
that Smad pathways are integral for a diverse range of biological
processes. Furthermore, deregulation of Smad-controlled miRNAs
has been implicated in numerous pathological conditions including
cancer [21–24], cardiovascular disease [25], and ﬁbrosis [26,27].
Understanding how Smad proteins regulate expression of miRNAs
and how these unique molecules in turn feed back onto Smad
expression are therefore critical elements in unraveling the di-
verse, context-dependent affect of TGF-b signaling.
That miRNAs comprise critical components of Smad signaling
pathways is illustrated by the large number of miRNAs whose
expression change in response to stimulation with TGF-b-family li-
gands. One recent study found 20 miRNAs induced and another
10 miRNAs inhibited in pulmonary arterial smooth muscle cells
(PASMC) stimulated with either TGF-b1 or BMP4 [28]. Similarly,
in mouse granulosa cells, TGF-b treatment was found to signiﬁ-
cantly alter the expression of 16 miRNAs [29]. In contrast, inter-
feron (IFN) stimulation of macrophages induced a signiﬁcant
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are likely to play an important role in the physiological activity of
TGF-b signaling.
4. Transcriptional regulation of miRNAs by Smads
Chromatin immunoprecipitation (CHIP) analyses reveal that
miRNA promoter elements closely resemble those of protein cod-
ing regions [31,32]. Therefore, it is not surprising that Smad pro-
teins control the transcription of a variety of miRNA genes. Both
in vitro and in vivomiRNA expression-proﬁling studies conﬁrm that
R-Smad proteins modulate a unique, but overlapping set of miR-
NAs [21,26,33,34]. For example, TGF-b induces both miR-216a
and miR-217 in glomerular mesengial cells via Smad binding ele-
ments (SBEs) in the miR-216 promoter [35]. Conversely, TGF-b-in-
duced Smad3/4 complex binding to the miR-24 promoter inhibits
the expression of miR-24 in myoblasts [36]. Transcriptional activa-
tion of miRNAs has distinct physiological signiﬁcance in vivo. For
instance, transcriptional repression of miR-29 by Smad-binding
to the promoter promotes renal ﬁbrosis [33].
Transcriptional activation of miRNA genes by Smad is sensitive
to canonical TGF-b signaling cascades. For instance, in mouse kid-
ney epithelial cells, induction of miR-192 by the TGF-b-speciﬁc R-
Smad, Smad3, can be reduced not only by siRNA against Smad3 but
also by overexpression of the antagonistic Smad protein Smad7
[26]. Furthermore, many miRNAs transcriptionally regulated by
Smads are known to be dependent on Smad4. One recent study
of TGF-b stimulated murine mammary gland epithelial cells indi-
cates that Smad4 knockdown results in deregulation of 28 miRNAs
[21]. In these cells, a Smad4 binding site within the miR-155 pro-
moter is critical for induction of this miRNA and subsequent down-
regulation of its target gene RhoA [21].
In addition to direct association of the Smad complex with the
miRNA promoters, Smads can indirectly modulate miRNA levels
through activation of transcription factors that associate with their
promoters. For instance, the miR-143145 gene locus, which en-
codes both miR-143 and miR-145, is transcriptionally regulated
by a complex composed of serum response factor (SRF) and myo-
cardin or myocardin related transcription factors (MRTFs)
[37,38]. TGF-b and BMP signaling increase miR-143 and miR-145
through activation of myocardin and MRTF, respectively [38]. Sim-
ilarly, induction of let-7d and let-7a by TGF-b is mediated by the
binding of Smad3 to a SBE in their promoters [27]. Interestingly,
higher let-7d expression is found in the lungs of patients with idi-
opathic pulmonary ﬁbrosis (IPF) as compared with control individ-
uals [27] and increased expression of let-7d and decreased
expression of its target HMGA2 correlate with higher TGF-b activ-
ity [26]. Therefore, deregulation of Smad-controlled miRNA may
have serious health consequences despite the relatively small ef-
fect of a single miRNA:mRNA interaction.
5. Epigenetic regulation of miRNAs
Like most transcription factors, Smad activity on the promoters
of target genes may be epigenetically modulated. For example,
mouse embryonic ﬁbroblasts (MEFs) transfected with the onco-
gene RasV12 become senescent as part of the response to aberrant
cell proliferation. Proﬁling of methylated loci following the expres-
sion of RasV12 identiﬁed multiple targets of the BMP-speciﬁc R-
Smad Smad1, that are induced or repressed by this process [39].
The promoter/enhancer structure of miRNAs largely reﬂects that
of RNA Pol II transcripts; similarly, the chromatin structure of miR-
NA promoters reﬂects that of RNA Pol II transcripts [31]. Thus, it is
likely that miRNA expression is susceptible to epigenetic changes
similar to protein coding genes. Epigenetic silencing is documentedfor several miRNAs, including miR-203 [40], miR-9 [41], and miR-
124 [42]. Therefore, we postulate it is only a matter of time before
epigenetic control of miRNAs by the TGF-b signaling pathway is
identiﬁed. Additionally, two TGF-b regulated miRNAs, miR-206
and miR-29, post-transcriptionally repress histone deacetylase 4
(HDAC4) induction and thereby inhibit myogenic differentiation
[43]. Thus TGF-b regulated miRNAs can themselves alter epigenetic
patterns as a way to mitigate more long-term gene regulation.
6. Post-transcriptional regulation of miRNAs by Smads
As described above, regulation of miRNA transcription by TGF-b
signaling largely conforms to the determinants of normal Smad
transcription. Close molecular dissection of TGF-b signaling re-
cently identiﬁed a novel role of Smads in post-transcriptionally
regulating miRNA biogenesis. In vascular smooth muscle cells
(VSMCs), TGF-b and BMP4 signaling promotes the maintenance
of a synthetic ‘‘contractile’’ phenotype, while lack of TGF-b or
BMP4 signaling results in a more proliferative phenotype [44]. This
phenotype is maintained, at least partially, due to the induction of
miR-21, which leads to downregulation of the miR-21 target pro-
gramed cell death protein 4 (PDCD4) [45]. Interestingly, the induc-
tion of miR-21 by TGF-b or BMP4 occurs without a corresponding
increase in pri-miR-21 and is not repressed by the RNA Pol II inhib-
itor a-amanitin [45]. Furthermore, unlike transcriptionally regu-
lated miRNAs, BMP and TGF-b-mediated induction of miR-21
occurs independent of Smad4, though it is completely dependent
on the R-Smads [45]. RNA CHIP experiments conﬁrm that R-Smads
bind directly to the pri-miR-21 hairpins in a ligand-dependent
manner [45]. Thus, mature miR-21 expression is induced by R-
Smad activity through a post-transcriptional mechanism (Fig. 2).
The mechanism for this process was actually hinted at by a
study performed to identify DNA regulatory proteins that promote
Smad3 activity. Through a yeast two-hybrid system using the car-
boxyl-terminal Mad homology 2 (MH2) domain of Smad3 as bait,
the DEAD-box RNA helicase protein p68 was identiﬁed as a Smad3
interacting protein [46]. As discussed above, p68 is an emerging
factor in pri- to pre-miRNA processing [16]. Consistent with this
observation the induction of miR-21 by BMP is dependent on
expression of p68 [45]. These data suggest a new mechanism of
miRNA regulation by Smads in which ligand stimulation induces
translocation of Smads to the nucleus where an association with
the Drosha microprocessor complex occurs. Further, it provides a
potential mechanism for Smad4-independent gene regulation
[47]. Interestingly, while many Smad4 deﬁcient cell types develop
normally, they are more prone to tumorigenic transformation [47].
This observation is consistent with the oncogenic function of many
TGF-b regulated miRNAs, including miR-21, which is known to
promote cell growth and migration as well as to inhibit apoptosis
in various types of tumors [48]. These results further suggest that
Smad-mediated regulation of miRNA processing may be important
during development.
To assess the structural characteristics of pri-miRNA regulated
by Smads, miRNA microarray proﬁling studies were performed
[28]. These studies found that, approximately 5% (20 of 377) of
miRNAs examined are induced by stimulation with both TGF-b
and BMP [28]. Interestingly, a subset of these miRNAs contain an
SBE-like RNA sequence (R-SBE) at the 30 end of their mature miRNA
sequence [28]. The R-SBE motif (50-CAGAC-30) is necessary for di-
rect binding of Smad proteins to pri-miRNA as illustrated by the
fact that mutation of this region abrogates Smad binding [45].
When introduced to miRNAs that do not contain R-SBE, this se-
quence motif is sufﬁcient to confer not only the association with
Smad but also TGF-b-dependent recruitment of Drosha and pro-
cessing [45].
Fig. 2. Regulation of miRNA expression by Smads. Smad-mediated regulation of miRNAs can be classiﬁed into two mechanisms: (i) transcriptional regulation of miRNAs by
Smads largely resembles the canonical TGF-b signaling pathway. Signal transduction leads to phosphorylation of an R-Smad, which induces the formation of an R-Smad/co-
Smad heterodimer. This complex is imported into the nucleus, binds the SBE and regulates, either positively or negatively, the transcription of miRNA genes. The pri-miRNAs
then undergoes normal miRNA processing. (ii) Post-transcriptional regulation of miRNA biogenesis acts on pri-miRNA in the nucleus. Phosphorylation of an R-Smad induces
nuclear localization. In the nucleus, R-Smad recognizes and binds an SBE-like sequence localized in the stem region of the pri-miRNA, and recruits the Drosha/DGCR8
microprocessor complex to the pri-miRNA. The microprocessor then promotes efﬁcient processing of the pri-miRNA into pre-miRNA.
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interactions with other proteins, such asDgcr8, to recruit and indi-
cate the appropriate site for pri-miRNA cleavage [15]. Recent evi-
dence suggests that proper RNA binding by microprocessor
components is a vital determinant of Drosha cleavage and affects
pre-mRNA and subsequently mature miRNA size and stability
[15]. Thus the location of the R-SBE within the hairpin structures
of the pri-miRNAs may be critical for modulating the ﬁnal mature
miRNA sequence.
Direct association of Smads with the pri-miRNAs is carried out
through the MH1 domain of Smad proteins [28], the same region
responsible for binding the SME to DNA during canonical Smad sig-
naling [20]. Although the pri-miRNA binding activity of R-Smads is
mediated by a molecular mechanism resembling that of DNA-bind-
ing, Smad4 is essential for the association with DNA [49] but not
with pri-miRNAs [45]. It is also important to note that the phos-
phorylation of R-Smads at the carboxyl-terminus serine residues
by the type I TGF-b receptors is not essential for the pri-miRNA
processing function of R-Smads. It was initially reported that the
phosphorylation of R-Smads promotes association of R-Smads with
Smad4 and translocation to the nucleus [49]. It is currently unclear
whether there is another protein which substitutes for the role of
Smad4 in nuclear import during processing of pri-miRNAs. A sub-
set of Smad proteins can enter the nucleus in a basal non-phos-
phorylated setting by a mechanism that does not require import
in 7 (Imp7) or Imp8, the canonical Smad nuclear-import factors
[50]. Thus R-Smads present in the nucleus in a form not bound
to Smad4 might preferentially interact with the Drosha/Dgcr8
microprocessor complex to promote miRNA maturation. However,this hypothesis does not address the TGF-b inducibility of
Smad-mediate miRNA maturation. Thus, inducible, Smad4-inde-
pendent transport of R-Smads into the nucleus remains an inter-
esting open avenue of research. Furthermore, kinases other than
the TGF-b receptors, such as mitogen activated protein kinase
(MAPK), glycogen synthase kinase 3 (GSK3) and extracellular sig-
nal-regulated kinase 2 (ERK2), can also affect the subcellular local-
ization of R-Smads and thereby alter pri-miRNA processing [51,52].
7. p68/p72-interacting transcription factors in addition to
Smads
The Drosha microprocessor complex is emerging as a critical
site for post-transcriptional regulation of miRNA biogenesis. Two
additional transcription factors, estrogen receptor-a (ERa) and
p53, are known to interact with the Drosha complex similar to R-
Smads [53,54]. In the case of p53, DNA damage induces p53 to
interact with the Drosha complex through p68 which promotes
pri- to pre-miRNA processing of multiple miRNAs, including miR-
143, miR-145, and miR-16-1 [53]. ERa is also recruited to the Dro-
sha microprocessor complex through p68 in response to estradiol
(E2) stimulation, however, the recruitment of ERa with the Drosha
complex inhibits the processing of pri-miR-143, pri-miR-145, pri-
miR-16-1, pri-miR-195, and pri-miR-125a [54]. Unlike the Smads,
the mechanisms of recognition for speciﬁc pri-miRNAs by p53 or
ERa remain unknown, however, it is plausible that further analyses
will unveil motifs within the pri-miRNA sequence recognized by
these transcription factors. Interestingly, miRNA proﬁling experi-
ments show that BMP4 and TGF-b stimulation in VSMCs also
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more, miR-206 is post-transcriptionally downregulated in the
C2C12 myoblast cell line following BMP2 treatment [55]. These
data suggest that in addition to positive regulation of pri- to pre-
miRNA processing, the Smad/Drosha/Dgcr8 complex may also inhi-
bit the maturation of pri-miRNAs.
The involvement of both p68 and p72 in Drosha processing in-
duced by diverse regulatory pathways and involving divergent
transcription factors suggests that these helicase proteins repre-
sent a general hub for the regulation of miRNA biogenesis. How-
ever, it remains unclear whether this mechanism is generally
applicable to other transcription factors. To date several additional
transcription factors, including MyoD [56], Runx2 [56], androgen
receptor [57] and b-catenin [54], have been found to interact with
p68 and p72. Thus it is likely that at least some of these proteins
might contribute to miRNA biogenesis. Interestingly, a meta-anal-
ysis of miRNA proﬁling found that there is no correlation between
the level of pre-miRNA and mature miRNA in cancer cells [58]. This
observation suggests that post-transcriptional regulatory mecha-
nisms play a pivotal role under pathological conditions as well as
in normal cells [58]. Finally, it is noteworthy that Smads may not
be the only members of the TGF-b signaling pathway that work
by promoting miRNA biogenesis. The protein small nuclear inter-
acting protein 1 (SNIP1), which was originally identiﬁed based on
its nuclear interaction with Smads, also associates with Drosha
[59]. Whether this interaction affects miRNA biogenesis, has not
yet been determined.
8. Reciprocal regulation: Control of Smad proteins by miRNAs
In addition to controlling miRNA expression, Smad proteins
can themselves be targeted by miRNAs. To date, most Smad pro-
teins are validated targets of at least one miRNA (see Table 1).
Smad expression can be modulated by miRNAs under normal
physiological conditions. For example, BMP2 signaling promotes
osteoblast differentiation at least in part by inhibiting the
expression of miR-135 and miR-199⁄ which target Smad5 and
Smad1, respectively [21,60]. Smads are also targeted by miRNAs
under pathological states; for instance in diffuse large B cell lym-
phoma miR-155 promotes proliferation by downregulating
Smad5 expression [23]. Even exogenous signals can alter Smad
expression through miRNAs. For example, miR-21 targets the
antagonistic Smad; Smad7, thus increasing basal TGF-b signaling
in hepatocytes following infection with the hepatitis C virusTable 1
miRNAs targeting Smads. miRNAs have been shown to target numerous Smad proteins und
validated to target individual Smad proteins and the biological signiﬁcance of this activity
Target miRNA Activity
miR-18a Smad2 Regulates TGF-b signaling in neu
miR-18a Smad4 Regulates TGF-b signaling in neu
miR-21 Smad7 Enhances TGF-b signaling in HCV
miR-135 Smad5 Inhibits osteoblast differentiation
miR-140 Smad3 In 3T3 cells, regulates expression
miR-145 Smad2 Alters macrophage sensitivity to
miR-146–5p Smad4 Suppresses TGF-b signaling in th
miR-155 Smad1 Induced by Epstein-Bar Virus (EB
miR-155 Smad2 Alters macrophage sensitivity to
miR-155 Smad5 Induced by Epstein-Bar Virus (EB
miR-155 Smad5 Promotes tumorigenesis in diffus
miR-192 Smad3 Contributes to collagen productio
miR-199a⁄ Smad1 Inhibits differentiation into chon
miR-200 Smad3 Promotes epithelial-mesenchyma
miR-224 Smad4 Enhances proliferation in mouse
miR-483–3p Smad4 Promotes proliferation of pancrea(HCV) [61]. Recently, Smad3 was identiﬁed as a target of miR-
140 which is regulated only at the protein level [62]. To identify
this protein, the authors ﬁrst identiﬁed mRNAs that were indi-
rect targets of miR-140 using mRNA arrays to ﬁnd genes modu-
lated by miR-140, but lacking a seed-sequence [62]. Next, they
characterized promoter elements that were underrepresented
in the off-target transcripts to identify putative binding sites of
the altered transcription factors [62]. Such studies illustrate both
the difﬁculty and the importance of considering the translational
effects of miRNA activity. It is likely that many more miRNAs
that target Smads remain to be discovered by studies that con-
sider changes occurring only at the protein levels.
Additional proteins related to the TGF-b-Smad signaling path-
ways, such as Smad inhibiting protein 1 (SIP1) [63,64] and TGF-b
super family receptors, such as ALK4 [65], the type II TGF-b
receptor [66] and the type II BMP receptor (BMPRII) [67], as well
as TGF-b ligand itself [68] are targeted by miRNAs. The case of
BMPRII is especially interesting as it is targeted by miR-21
whose expression is elevated by Smad activity [67]. It is cur-
rently unclear whether miR-21-dependent regulation of BMPRII
plays a role in Smad signaling as BMPRII expression remains
high throughout the course of BMP stimulation, at least in
VSMCs (A.H., unpublished data). It is possible that miRNA regu-
lation of BMPRII acts as a negative feedback loop to limit the
duration of Smad activity.9. Conclusion
In this chapter, we summarized a critical role of Smad proteins
in the regulation of miRNA biogenesis. Two primary modes of reg-
ulation by Smads are; (i) transcriptional regulation of miRNA genes
by nuclear translocation of R-Smad/co-Smad heterodimers, associ-
ation with the DNA sequence motif known as SBE, and modulation
of transcription, and (ii) post-transcriptional regulation of pri- to
pre-miRNA processing by R-Smad through the recruitment and
activation of the Drosha/Dgcr8/p68 microprocessor complex. Addi-
tional mechanisms of miRNA regulation by the TGF-b super family
of growth factors are likely to be uncovered in the future. Such
mechanisms are an important component of understanding how
cells integrate the complex repertoire of miRNAs whose expression
levels are ﬁne-tuned by TGF-b signaling pathways and transmit a
precise signal in order to control normal development and main-
tain homeostasis.er various cellular conditions. Below is a list of miRNAs that have been experimentally
.
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